Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $13.82 billion. The enterprise value is $24.00 billion.
| Market Cap | 13.82B |
| Enterprise Value | 24.00B |
Important Dates
The last earnings date was Tuesday, April 29, 2025, before market open.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 92.89 million shares outstanding. The number of shares has decreased by -6.73% in one year.
| Current Share Class | 92.89M |
| Shares Outstanding | 92.89M |
| Shares Change (YoY) | -6.73% |
| Shares Change (QoQ) | -0.90% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 92.47% |
| Float | 92.15M |
Valuation Ratios
The trailing PE ratio is 9.86 and the forward PE ratio is 11.75. THC's PEG ratio is 1.16.
| PE Ratio | 9.86 |
| Forward PE | 11.75 |
| PS Ratio | 0.69 |
| Forward PS | 0.65 |
| PB Ratio | 3.31 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.79 |
| P/OCF Ratio | 6.07 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.72, with an EV/FCF ratio of 16.99.
| EV / Earnings | 16.49 |
| EV / Sales | 1.17 |
| EV / EBITDA | 5.72 |
| EV / EBIT | 7.10 |
| EV / FCF | 16.99 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 1.52.
| Current Ratio | 1.78 |
| Quick Ratio | 1.53 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 2.86 |
| Debt / FCF | 9.33 |
| Interest Coverage | 4.16 |
Financial Efficiency
Return on equity (ROE) is 28.82% and return on invested capital (ROIC) is 9.97%.
| Return on Equity (ROE) | 28.82% |
| Return on Assets (ROA) | 7.26% |
| Return on Invested Capital (ROIC) | 9.97% |
| Return on Capital Employed (ROCE) | 13.63% |
| Revenue Per Employee | $209,388 |
| Profits Per Employee | $14,847 |
| Employee Count | 98,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 33.11 |
Taxes
In the past 12 months, THC has paid $577.00 million in taxes.
| Income Tax | 577.00M |
| Effective Tax Rate | 19.70% |
Stock Price Statistics
The stock price has increased by +21.16% in the last 52 weeks. The beta is 1.63, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | +21.16% |
| 50-Day Moving Average | 129.40 |
| 200-Day Moving Average | 143.20 |
| Relative Strength Index (RSI) | 65.13 |
| Average Volume (20 Days) | 1,553,455 |
Short Selling Information
The latest short interest is 2.03 million, so 2.18% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 2.43M |
| Short % of Shares Out | 2.18% |
| Short % of Float | 2.20% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, THC had revenue of $20.52 billion and earned $1.46 billion in profits. Earnings per share was $15.09.
| Revenue | 20.52B |
| Gross Profit | 8.29B |
| Operating Income | 3.38B |
| Pretax Income | 3.76B |
| Net Income | 1.46B |
| EBITDA | 4.20B |
| EBIT | 3.38B |
| Earnings Per Share (EPS) | $15.09 |
Balance Sheet
The company has $3.00 billion in cash and $13.17 billion in debt, giving a net cash position of -$10.17 billion or -$109.50 per share.
| Cash & Cash Equivalents | 3.00B |
| Total Debt | 13.17B |
| Net Cash | -10.17B |
| Net Cash Per Share | -$109.50 |
| Equity (Book Value) | 8.65B |
| Book Value Per Share | 45.01 |
| Working Capital | 3.46B |
Cash Flow
In the last 12 months, operating cash flow was $2.28 billion and capital expenditures -$864.00 million, giving a free cash flow of $1.41 billion.
| Operating Cash Flow | 2.28B |
| Capital Expenditures | -864.00M |
| Free Cash Flow | 1.41B |
| FCF Per Share | $15.20 |
Margins
Gross margin is 40.38%, with operating and profit margins of 16.47% and 7.09%.
| Gross Margin | 40.38% |
| Operating Margin | 16.47% |
| Pretax Margin | 14.27% |
| Profit Margin | 7.09% |
| EBITDA Margin | 20.44% |
| EBIT Margin | 16.47% |
| FCF Margin | 6.88% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.73% |
| Shareholder Yield | n/a |
| Earnings Yield | 10.53% |
| FCF Yield | 10.21% |
Analyst Forecast
The average price target for THC is $173.31, which is 16.45% higher than the current price. The consensus rating is "Buy".
| Price Target | $173.31 |
| Price Target Difference | 16.45% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 3.45% |
| EPS Growth Forecast (5Y) | -6.73% |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 0.25:1.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.25:1 |
Scores
THC has an Altman Z-Score of 1.78 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 6 |